News |

Five political developments to follow in Q1 2018

By Matthew Elliott, Senior Political Adviser, Shore Capital   Anybody hoping that the world would enter a period of calm […]

 

News |

Phone-obsessed, self-entitled and risking Britain’s future

  Howard Shore talks to William Turvill in the Financial Mail on Sunday about Brexit, productivity and millennials. The full […]

 

News |

SCGL Performance of Funds – November 2017

The following table gives the performance for the month ended 30 November 2017 of the funds managed by the Group’s […]

 

News |

Result of Annual General Meeting

Shore Capital Group Limited 28 December 2017   Shore Capital Group Limited, the independent investment group specialising in capital markets, […]

 

News |

Shore Capital Appointed as Joint Corporate Broker to Gfinity

Shore Capital has been appointed with immediate effect as joint corporate broker to Gfinity – a leading international esports entertainment group.  […]

 

News |

Shore Capital acts as Lead Manager to Savannah Petroleum’s proposed $125 million placing

  Shore Capital acts as Lead Manager to Savannah Petroleum’s proposed $125 million placing to fund, inter alia, the cash […]

 

News |

Update on Puma Social Care Investments Limited

  Puma Social Care Investments Limited (PSCI), an associate of the Shore Capital Group Limited (Group) in which it has […]

 

News |

Shore Capital acts as Financial and Rule 3 Adviser to Styles & Wood in £42.5 million takeover

  Shore Capital is acting as Financial and Rule 3 Adviser to Styles & Wood Group PLC, an integrated property […]

 

News |

Shore Capital acts as Co-ordinating Bookrunner and Joint Broker for Echo Energy Plc

  Echo Energy plc, the South and Central American focused upstream gas company, is pleased to announce that an admission […]

 

News |

Shore Capital Group Limited – Posting of Notice of AGM 2017

Shore Capital Group Limited (the “Company”), the independent investment group specialising in capital markets, principal finance and asset management, announces […]

 

News |

Shore Capital appointed as Joint Broker to Mothercare Plc

  Mothercare plc (or ‘the Company’), the leading global retailer for parents and young children, announces the appointment with immediate […]

 

News |

Shore Capital acts as Joint Bookrunner on £3m Placing for Touchstone Exploration Inc.

  Touchstone Exploration Inc. (“Touchstone” or the “Company”) (TSX / LSE: TXP), announces that it intends to complete a private […]

 

News |

Risk of Corbyn government greater than Brexit uncertainty

CNBC news discusses future political leadership and tax policy in the U.K with Howard Shore, founder and Executive Chairman of […]

 

News |

Shore Capital appointed as Joint Broker to Salt Lake Potash Ltd

  Shore Capital has today been appointed as Joint Broker to Salt Lake Potash Ltd (LSE: SO4). Salt Lake Potash […]

 

News |

Shore Capital’s Tara Raveendran unveiled as one of the 50 female leaders in BioBusiness

  We’re proud to announce that Tara Raveendran, Healthcare Analyst at Shore Capital, has been unveiled as one of the […]

 

News |

SCGL Performance of Funds – September 2017

The following table gives the performance for the month ended 30 September 2017 of the funds managed by the Group’s […]

 

News |

Shore Capital acts as Joint Bookrunner on US$23.5m Placing for Victoria Oil & Gas Plc

  Cameroon-focused gas producer, Victoria Oil & Gas Plc (VOG), has announced the successful completion of a proposed placing and […]

 

News |

Politicians must make life easier for business in post-Brexit Britain

  Howard Shore, Founder, Puma Brandenburg Ltd & Shore Capital Group Ltd Ahead of last year’s referendum, I was optimistic […]

 

News |

Shore Capital sponsors ‘AIM Transaction of the Year’ at the prestigious AIM Awards 2017

  Shore Capital is proud to have been one of the sponsors at this year’s prestigious AIM Awards 2017.  Now […]

 

News |

Shore Capital acts as Sole Bookrunner for Judges Scientific Plc

  Completion of Director Placing Judges Scientific, a group involved in the buy and build of scientific instrument businesses, announces […]

 

News |

Shore Capital acts as Joint Financial Adviser to Zenith Hygiene

  Shore Capital is acting as Joint Financial Adviser to Zenith Hygiene Group PLC, a UK manufacturer of cleaning and […]

 

News |

Shore Capital acts as Joint Bookrunner for Randall & Quilter Investment Holdings Ltd

  Randall & Quilter Investment Holdings Ltd (“R&Q”, the “Group” or the “Company”) Placing and open offer to raise up […]

 

News |

Shore Capital acts as Joint Bookrunner on £25m Placing for Earthport Plc

  Earthport Plc (“Earthport” or the “Company”) Results of Placing Earthport (AIM: EPO) is pleased to announce the result of […]

 

News |

Shore Capital’s Yuen Low shortlisted for this year’s City A.M. ‘Analyst of the Year’ Award

  With volatility and uncertainty stalking a range of sectors, it is a tricky time to be an analyst. Which […]

 

News |

Shore Capital acts as Sole Bookrunner for Canadian Overseas Petroleum Limited

  Canadian Overseas Petroleum Limited (the “Company”) (TSXV: XOP) (LSE: COPL), is pleased to announce an offering of common shares […]

 

News |

Shore Capital acts as Nomad and Joint Bookrunner for €46.9m placing for Applegreen plc

  Applegreen plc (“Applegreen” or the “Company”), is pleased to announce the successful completion of the placing of new Ordinary […]

 

Reports & Accounts |

SCGL – Interim results for the six months ended 30 June 2017

  Shore Capital Group Limited (“Shore Capital,” the “Group” or the “Company”) Interim results for the six months ended 30 […]

 

News |

SCGL Performance of Funds – August 2017

The following table gives the performance for the month ended 31 August 2017 of the funds managed by the Group’s […]

 

News |

SCGL Performance of Funds – June 2017

The following table gives the performance for the month ended 30 June 2017 of the funds managed by the Group’s […]

 

News |

Shore Capital acts as Nomad, Joint Broker and Joint Bookrunner to AMRYT Pharma

  Amryt, the pharmaceutical company focused on best-in-class treatments for rare and orphan diseases, announces that it has raised €15.0 […]